Myoba S

No ORCID on file · 2 papers in corpus · active 2024
2024
Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study.
BMC cancer ·doi:10.1186/s12885-024-12827-0

BackgroundEndometrial cancer is the most common gynecological malignancy; however, there is no useful blood diagnostic biomarker. This study aimed to determine the utility of tissue factor pathway inhibitor 2 (TFPI2), a biomarker of ovarian…

2024
Tissue factor pathway inhibitor 2 (TFPI2) is a potential serum biomarker for clear cell renal carcinoma.
Scientific reports ·doi:10.1038/s41598-024-80248-x

Renal and ovarian clear cell carcinoma (CCC) are both characterized by a clear cytoplasm and exhibit similar genomic alterations and clinical characteristics. We hypothesized that both CCCs may share clinical biomarker. Tissue factor pathwa…